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Oxidative stress and dysregulation of superoxide dismutase Oxidative reactions that fuel various biochemical, bio-
and NADPH oxidase in renal insufficiency. physical and mechanical functions of the aerobic organ-
Background. Chronic renal failure (CRF) is associated with isms are coupled with continuous generation of highlyoxidative stress, the mechanism of which remains uncertain.
reactive and potentially cytotoxic reactive oxygen speciesSuperoxide is the primary oxygen free radical produced in the
(ROS). Under normal conditions, the ROS produced inbody, NAD(P)H oxidase is the major source of superoxide
production and superoxide dismutase (SOD) is responsible for the course of metabolism are contained by the natural
removal of superoxide. We hypothesized that CRF-induced antioxidant system that protects the functional and struc-
oxidative stress may be due to increased production and/or tural molecules against ROS-mediated modifications,decreased dismutation of superoxide.
thereby preventing cytotoxicity and tissue damage. TheMethods. Immunodetectable superoxide dismutase isoforms
natural antioxidant system consists of a series of antioxi-(Cu Zn SOD and Mn SOD), as well as, NAD(P)H oxidase
(gp91 phox subunit) proteins and xanthine oxidase (XO) activ- dant enzymes as well as numerous endogenous and di-
ity were determined in the kidney and liver of CRF (5/6 ne- etary antioxidant compounds that are capable of reacting
phrectomized) and sham-operated control rats. Subgroups of
with and inactivating ROS.animals were treated with SOD-mimetic drug, tempol and
Under a variety of abnormal conditions, the rate ofblood pressure and urinary nitric oxide metabolites (NOx) were
monitored. ROS production may exceed the natural antioxidant ca-
Results. The CRF group showed marked down-regulations pacity leading to oxidative stress in which uncontained
of CuZn SOD and Mn SOD and significant up-regulation of ROS can attack the functional or structural molecules,
gp91 phox in the liver and kidney, which are among the meta-
and thereby produce tissue injury and dysfunction. Oxi-bolically most active tissues. In contrast, XO activity was de-
dative stress can occur as a result of either excess ROSpressed in both tissues. Arterial pressure and nitrotyrosine
abundance were elevated while urinary NOx excretion was production, or impaired antioxidant system, or a combi-
depressed, pointing to increased NO inactivation by superoxide nation thereof. The primary ROS produced in the course
and decreased NO availability in CRF animals. Administration of oxygen metabolism is superoxide, which is a highlyof SOD-mimetic agent, tempol, for one week, ameliorated
reactive, cytotoxic ROS. Superoxide is dismutated to ahypertension, reduced nitrotyrosine abundance and increased
far less reactive product, hydrogen peroxide (H2O2), byurinary NOx excretion in the CRF animals.
Conclusions. CRF is associated with depressed SOD and a family of metalloenzymes known as superoxide dismu-
elevated NAD(P)H oxidase expression, which can contribute tase (SOD). Thus, SOD is the front line of defense
to oxidative stress by increasing superoxide. This is evidenced against ROS-mediated injury. Three isoforms of SODby favorable response to administration of SOD-mimetic drug,
have been identified thus far. These include the copper-tempol, and increased nitrotyrosine that is the footprint of NO
interaction with superoxide. zinc SOD (Cu Zn SOD), which is present in the cyto-
plasm, manganese SOD (Mn SOD), which is found in the
mitochondria, and extracellular SOD (ECSOD), which
exists in the interstitial fluid, plasma, lymph and synovial
fluid [1].
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Oxidative stress has emerged as a major feature ofoxygen-free radicals, anemia, cardiovascular disease, lipid peroxida-
tion, advanced glycosylation end products, xanthine oxidase. chronic renal failure (CRF). This conclusion is based on
the following observations. First, plasma concentrationReceived for publication May 16, 2002
of lipid peroxidation products is markedly elevated, de-and in revised form June 28, 2002
Accepted for publication August 7, 2002 noting enhanced ROS interaction with the lipid mole-
cules in CRF [2–5]. Second, CRF results in accumulation 2003 by the International Society of Nephrology
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of advanced glycated end products (AGE) and advanced monitored for six weeks after nephrectomy and sham
operation. In an attempt to discern the possible elevationlipoxidation end products (ALE) pointing to modifica-
tion of protein molecules by ROS-mediated generation of superoxide activity, subgroups of the CRF and control
animals were treated with the SOD-mimetic drug, tem-of reactive carbonyl compounds and lipoperoxides, re-
spectively [6]. Third, recent studies from our laboratories pol (Sigma Chemical Co., St. Louis, MO, USA) added
to the drinking water at 1 mmol/L for one week begin-have demonstrated enhanced ROS-mediated nitric oxide
inactivation, protein nitration, functional NO deficiency ning on week 5 post-nephrectomy.
At the conclusion of the six-week observation period,and hypertension in CRF [7, 8].
The precise mechanism(s) of CRF-induced oxidative animals were placed in individual metabolic cages for a
timed urine collection. The animals were anesthetizedstress has not been elucidated. However, earlier studies
carried out to discern the cause of shortened erythrocyte (pentobarbital 50 mg/kg, IP) and exsanguinated by car-
diac puncture. Remnant kidney and liver were immedi-life span demonstrated a significant reduction of SOD
activity and antioxidant capacity in erythrocytes of CRF ately harvested, cleaned and snap-frozen in liquid nitro-
gen. Plasma and frozen tissues were then stored at70Cpatients [9–12]. It is uncertain as to whether the reported
reduction of erythrocyte SOD activity is due to inhibition until processed. The experimental protocol employed in
the study was approved by the Institutional Animal Careof SOD by the uremic milieu or an actual reduction of
SOD protein. Likewise, it is unclear as to whether the and Use Committee of the University of California, Ir-
vine.reported reduction of SOD activity in CRF is confined
to the uremic erythrocyte or is a systemic phenomenon.
Measurements of SOD and NAD(P)H oxidase proteinsIf present, systemic SOD deficiency can account, in part,
for the CRF-induced oxidative stress. Homogenates (25% wt/vol) of kidney, heart (left ventri-
cle), thoracic aorta and brain were prepared in 10 mmol/LNicotinamide adenine dinucleotide phosphate [NAD(P)H]
oxidases are the major source of superoxide production HEPES buffer, pH 7.4, containing 320 mmol/L sucrose,
1 mmol/L ethylenediaminetetraacetic acid (EDTA), 1in phagocytes and vascular tissue [13]. Thus, up-regulation
of NADPH oxidase abundance or activity can lead to mmol/L dithiothreitol (DTT), 10 g/mL leupeptin, 2
g/mL aprotinin and 1 mmol/L phenylmethylsulfonyloxidative stress. To our knowledge, the effect of renal
insufficiency on tissue NAD(P)H oxidase has not been fluoride (PMSF) at 0 to 4C with a tissue grinder fitted
with a motor-driven ground glass pestle. Homogenatesinvestigated.
We hypothesized that CRF may lead to down-regula- were centrifuged at 9000  g for 10 minutes at 4C
to remove nuclear fragments and tissue debris withouttion of SOD and up-regulation of NAD(P)H oxidase
expression in major organs. We further considered that if precipitating membrane fragments. A portion of the su-
pernatant was used for the determination of total proteinthis hypothesis is true, administration of a cell-permeable
SOD-mimetic agent should ameliorate oxidative stress, concentration by using a Bio-Rad kit (Hercules, CA,
USA).reduce ROS-mediated nitric oxide inactivation and im-
prove the associated hypertension. The present study Total cellular protein (Cu Zn SOD, 1 g; Mn SOD
and NADPH oxidase, 20 g each) was electrophoresedwas undertaken to test this hypothesis.
in 4 to 20% Tris-glycine sodium dodecyl sulfate (SDS)
polyacrylamide gels (Novex, San Diego, CA, USA). Pro-
METHODS
teins were transferred onto nitrocellulose membranes
Study groups (Millipore Corp., Bedford, MA, USA), blocked in 5%
dry milk in T-TBS (0.02 mol/L Tris/0.15 mol/L NaCl, pHMale Sprague Dawley rats weighing 230 to 250 g (Har-
lan Sprague Dawley Inc., Indianapolis, IN, USA) were 7.5 containing 0.1% Tween 20) at room temperature
for three hours, washed three times with T-TBS andused in this study. Animals were housed in a climate-
controlled space with 12-hour day and night cycles and incubated with the primary antibodies (both the Cu Zn
SOD and Mn SOD, 1:1000; NADPH oxidase, 1:2000)were provided free access to regular rat chow and water.
The animals were randomly assigned to the CRF and for three hours at room temperature. Cu Zn SOD and
Mn SOD antibodies were purchased from Calbiochemsham-operated control groups. The CRF group under-
went 5/6 nephrectomy by surgical resection of the upper Inc. (San Diego, CA, USA). For NADPH oxidase, we
used the monoclonal antibody against the gp91 phoxand lower thirds of left kidney, followed by right ne-
phrectomy four days later. The control group underwent subunit (Transduction Labs, Lexington, KY, USA). After
washing five times with T-TBS, the blots were incubatedsham operation. The procedures were carried out under
general anesthesia (pentobarbital 50 mg/kg IP) using with secondary antibodies (anti-sheep for both the Cu
Zn and Mn SOD, 1:2000 and anti-mouse for NADPHstrict hemostasis and aseptic techniques. The nephrec-
tomy procedures were accomplished via dorsal incisions oxidase, 1:2000) conjugated with horseradish peroxidase
at room temperature for two hours. After washing fiveas described in our earlier studies [14]. Animals were
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times with T-TBS, the membrane was developed using protein at 21C. The subsequent conversion of urate to
enhanced chemiluminescent (ECL) reagent (Amersham allantoin and the influence of this reaction on xanthine
Life Science Inc., Arlington Heights, IL, USA) and sub- oxidase activity measurement are presumed negligible
jected to autoluminography for one to five minutes. The and have been ignored because in the presence of excess
autoluminographs were scanned with a laser densitometer xanthine, the maximum initial velocity of the reaction is
(Model PD 1211; Molecular Dynamics, Sunnyvale, CA, being measured.
USA) to determine the relative optical densities of the
Data analysisbands. In all instances, the membranes were stained with
Ponceau stain, to verify the uniformity of protein load Analysis of variance (ANOVA), the Student t test and
and transfer efficiency across the test samples. regression analysis were used in statistical evaluation of
the data that are presented as mean  SEM. P values
Measurement of arterial pressure
0.05 were considered significant.
Arterial pressure was determined by tail plethysmo-
graphy (Harvard Apparatus, Natick, MA, USA) as de-
RESULTSscribed in our earlier studies [5].
General data
Measurement of urinary NO metabolites (NOx) The CRF group exhibited a significant reduction in
Urinary concentration of NOx (total NO2 and NO3) was creatinine clearance (1.29  0.34 vs. 3.72  0.22 mL/
determined by means of the Sievers model 270B nitric min, P 0.01) and a marked increase in arterial pressure.
oxide analyzer (Sievers Instruments, Boulder, CO, USA) Body weight obtained at the end of the observation pe-
as described in our earlier studies [14]. riod was significantly lower in the CRF group (340 20 g)
as compared with the normal control group (398  18 g).Measurement of tissue nitrotyrosine
Likewise, hematocrit was significantly lower in the CRF
Nitrotyrosine abundance in the plasma was deter- group than that found in the sham-operated controls.
mined by Western blot analysis as described in our ear- The CRF group exhibited a marked reduction in urinary
lier studies [15]. The anti-nitrotyrosine antibody em- NOx excretion.ployed in these measurements was purchased from
Upstate Biotechnology Inc (Lake Placid, New York, NY, Markers of oxidative stress
USA). In an attempt to exclude nonspecific reactivity,
The CRF group showed a significant increase inthe Western blot procedures were repeated with the
plasma nitrotyrosine abundance (32.5  1.9 vs. 10.2 omission of the respective primary antibodies. No reac-
1.5 relative optical densities; P 0.001). This was accom-tivity was observed with the secondary antibody when
panied by a significant increase in plasma malondialde-primary antibody was omitted.
hyde (1.8  0.1 vs. 1.2  0.1 mol/L, P  0.05). The
constellation of these findings points to enhanced ROS-Measurement of xanthine oxidase activity
mediated inactivation of nitric oxide, as well as, oxidationXanthine oxidase activity of the liver and kidney tis-
of lipid molecules in CRF animals.sues were determined as described in our earlier studies
[16]. Briefly, 600 mg of liver and kidney tissues were Effect of tempol
each homogenized (30-s pulse) in 10 mL of a cold buffer
Administration of the cell-permeable SOD-mimeticsolution with a Brinkmann Polytron tissue/cell disrupter
drug for one week resulted in a significant amelioration(Model PT 10/35; Brinkman Instruments Inc., Westbury,
of hypertension and a significant rise in urinary NOxNY, USA). The buffer solution contained 300 mmol/L
excretion in the tempol-treated CRF group. Tempol ad-mannitol, 20 mmol/L N-hydroxyethylpiperazine-N1–2-
ministration had no significant effect on either creatinineethanesulfonic acid (HEPES), and 13.3 mmol/L Tris (pH
clearance (1.35 0.2 mL/min) or body weight (350 8 g)7.4). Before storage at 80C, aliquots of these hemo-
in the treated CRF group. Although mean hematocrit ingenates were appropriately diluted for both enzyme ac-
the tempol-treated group was higher than that found intivity measurements and protein determination by use
the untreated CRF group, the difference did not attainof the Bradford method (Bio-Rad Protein Kit).
statistical significance. Data are shown in Figure 1.Xanthine oxidase activity was determined in aliquots
of tissue homogenates by measuring an increase in ab-
Tissue SOD protein abundancesorbance at 292 nm due to urate formed from excess
The CRF group exhibited a significant reduction inxanthine used as a substrate in a pyrophosphate buffer
hepatic tissue abundance of both Cu Zn SOD and Mn(0.1 mol/L, pH 8). A unit of xanthine oxidase is defined
SOD as compared with values found in the normal con-as the amount of enzyme required to catalyze the forma-
tion of 1 nmol of urate per minute per milligram of trol group (Figs. 2 and 3). Similarly, the CRF group
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Fig. 1. Systolic arterial pressure, urinary NO metabolite (NOx) excre-
tion and hematocrit in sham-operated control (CTL), untreated chronic
renal failure (CRF) and tempol-treated CRF (CRFT) groups (N 
6 in each group; *P  0.01).
showed a significant reduction in the kidney tissue Cu Fig. 2. Representative Western blots and group data depicting Cu Zn
SOD protein abundance in the (A ) kidney and (B ) liver of rats withZn SOD and Mn SOD proteins (Figs. 2 and 3).
chronic renal failure (CRF) and sham-operated control (CTL) group
(N  6 in each group; *P  0.05).
Tissue gp 91 phox protein and xanthine oxidase activity
The protein abundance of the gp91 phox subunit of
the NAD(P)H oxidase was significantly increased in the
a significant increase in nitrotyrosine abundance, which isremnant kidney and liver of the CRF animals, as com-
the footprint of NO-ROS-protein interaction confirmingpared with that found in the sham-operated controls (Fig.
our earlier studies [7]. These findings substantiated the4). In contrast, xanthine oxidase activity was markedly
presence of oxidative stress and ROS-mediated modifi-reduced in both liver and kidney tissues of the CRF
cation of NO, lipid and protein molecules in the CRFanimal as compared with the sham-operated controls
animals. In a series of earlier studies, we and others have(Fig. 5).
shown that ROS-mediated inactivation and sequestra-
tion of NO contributes to the pathogenesis of hyperten-
DISCUSSION sion by limiting NO availability in CRF and various other
forms of genetic and acquired hypertension [5, 7, 15,In confirmation of the earlier studies [2–5], the un-
treated CRF group showed a marked elevation of plasma 17–26]. In fact, we have recently shown that induction
of oxidative stress by glutathione depletion can causemalondialdehyde, which is a marker of lipid peroxidation
by ROS. In addition, the untreated CRF rats exhibited an antioxidant-remediable hypertension marked by avid
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Fig. 3. Representative Western blots and group data depicting Mn
SOD protein abundance in the (A ) kidney and (B ) liver of rats with
chronic renal failure (CRF) and sham-operated control (CTL) group Fig. 4. Representative Western blots and group data depicting gp91
(N  6 in each group; *P  0.05). phox subunit of NADPH oxidase protein abundance in the (B ) kidney
and (A ) liver of rats with chronic renal failure (CRF) and sham-operated
control (CTL) group (N  6 in each group; *P  0.05).
inactivation and sequestration of NO in genetically nor-
mal, otherwise, intact rats [25]. The latter study provided
cytoplasmic (Cu Zn SOD) and mitochondrial (Mn SOD)convincing evidence that oxidative stress, per se, can
isoforms in the liver and kidney of the study animals.cause hypertension.
The kidney and liver were chosen since these organs areAdministration of the cell-permeable SOD-mimetic
among the metabolically most active tissues and, as such,drug, tempol, resulted in a significant fall in arterial pres-
abundantly express and heavily depend on various anti-sure and a significant rise in urinary NOx excretion in
oxidant enzymes especially SOD.the CRF animals. In contrast, administration of the cell-
The CRF group exhibited a significant reduction ofimpermeable native SOD protein carried out in our ear-
both Cu Zn SOD and Mn SOD protein abundance inlier studies [5] failed to significantly alter either arterial
the liver and kidney tissues. The reduction in the liverpressure or urinary NOx excretion in this model. These
and kidney Cu Zn SOD protein abundance in the CRFobservations point to the possible role of deficiency of
animals, shown for the first time here, parallels the pre-intracellular SOD isoforms as opposed to the extracellu-
viously reported reduction of SOD enzymatic activity inlar SOD in blood pressure regulation and NO metabo-
lism in the CRF animals. Therefore, we determined the the erythrocytes of patients with chronic renal failure
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are the main source of superoxide in cardiovascular tissues
[13, 29–32]. NAD(P)H oxidases are membrane-associated
enzymes consisting of two membrane-spanning subunits,
gp91 phox and p22 phox, which serve as electron transfer
components of the enzyme, as well as, three cytoplasmic
subunits, that is, p47 phox, p67 phox and the G protein
rac, which modulate the enzyme activity. These enzymes
catalyze the one-electron reduction of molecular oxygen
using NAD(P)H as the electron donor: NAD(P)H 
2O2→H  NAD(P)  2O•2. In leukocytes, fibroblasts
and endothelial cells, electrons derived from intracellular
NAD(P)H is transferred to extracellular oxygen leading
to production of superoxide in the extracellular space.
However, in the vascular smooth muscle, superoxide is
produced in the intracellular space [29, 33–35].
Increased NAD(P)H oxidase-derived superoxide pro-
duction has been implicated in the pathogenesis of arth-
erosclerotic plaque formation and rupture [13]. In addi-
tion, increased superoxide activity has been shown to
play an important part in the pathogenesis of different
genetic and acquired forms of hypertension in experimen-
tal animals, such as, spontaneously hypertensive rats [17,
18, 36, 37], angiotensin-infused rats [32, 38, 39], salt-sensi-
tive Dahl rats [19] and lead-exposed rats [21]. The combi-
Fig. 5. Xanthine oxidase enzymatic activity of the (A ) liver and (B ) nation of increased NAD(P)H oxidase abundance andkidney tissues in the rats with chronic renal failure (CRF) and sham-
SOD deficiency can lead to a marked increase in super-operated control (CTL) group (N  6 in each group; *P  0.01).
oxide activity in the CRF animals. This supposition is
supported by the favorable response to administration of
superoxide scavenger, tempol, in the treated CRF group.
[9–12]. Since mature circulating erythrocytes lack nu- In contrast to NAD(P)H, oxidase, xanthine oxidase
cleus and mitochondria, the reported measurements of activity was markedly reduced in both kidney and liver
erythrocyte SOD enzymatic activity necessarily reflect of CRF animals, confirming our earlier studies [16]. This
that of cytoplasmic, that is, Cu Zn SOD. Accordingly, observation argues against the role of xanthine oxide as
CRF appears to cause diffuse down-regulation of Cu Zn a major source of ROS in CRF animals. As reviewed
SOD. In addition to Cu Zn SOD deficiency, the CRF by Griendling et al [13], similar conclusions have been
group exhibited significant down-regulation of mito- reached by investigators examining other models [27, 28].
chondrial Mn SOD protein abundance in the kidney and The CRF animals employed in the present study ex-
liver tissues. Taken together, the data indicate that CRF hibited a marked increase in plasma nitrotyrosine abun-
results in a severe reduction of cellular SOD isoforms. dance, confirming our earlier studies [7]. Superoxide and
Given the pivotal contribution of SOD to the cellular other ROS avidly react with and inactivate NO, a process
antioxidant defense system, the CRF-induced SOD de- that can lead to functional NO deficiency and formation
ficiencies shown in our current study must contribute, in of highly reactive and cytotoxic products, such as, perox-
part, to the pathogenesis of the associated oxidative stress ynitrite and peroxynitrous acid (O•2  NO → ONOO)
in this model. [40]. These compounds can, in turn, react with and mod-
The reduction in cellular SOD isoforms in the CRF ify various functional and structural molecules producing
animals was accompanied by a significant elevation of tissue injury and dysfunction. Therefore, alleviation of
gp91 phox subunit of NAD(P)H oxidase, which is the oxidative stress by antioxidant therapy should reduce
major source of superoxide production in the cardiovas- ROS-mediated NO inactivation, enhance NO availabil-
cular tissues. Virtually all cardiovascular cell types pro- ity and improve hypertension. This was clearly exempli-
duce ROS that play an important role in numerous physi- fied by administration of tempol, which ameliorated hy-
ological processes as well as in the pathogenesis of pertension and improved NO availability as evidenced
cardiovascular disease [13]. Earlier studies suggested by increased urinary NOx excretion in the CRF animals
xanthine oxidase as a source of superoxide production employed in the present study.
in the vascular tissue [27, 28]. However, recent investiga- In conclusion, CRF induced by renal mass reduction
in genetically normal rats resulted in oxidative stress astions have clearly demonstrated that NAD(P)H oxidases
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